Merck & Siemens join forces to accelerate AI drug discovery and development
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated